Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective (Q33857362)

29 July 2017

title

Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective (English)

1 reference

29 July 2017

Findlay JW

1 reference

29 July 2017

Smith WC

1 reference

29 July 2017

Lee JW

1 reference

29 July 2017

Nordblom GD

1 reference

29 July 2017

Das I

1 reference

29 July 2017

DeSilva BS

1 reference

29 July 2017

Khan MN

1 reference

29 July 2017

Bowsher RR

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Journal of Pharmaceutical and Biomedical Analysis

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

1249-1273

1 reference

An analysis of the Washington Conference Report on bioanalytical method validation.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Validation of bioanalytical chromatographic methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Conceptual and statistical issues in the validation of analytic dilution assays for pharmaceutical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

An assessment of the 4-6-20 rule for acceptance of analytical runs in bioavailability, bioequivalence, and pharmacokinetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

The role of pharmacokinetics in the development of biotechnologically derived agents

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

The relevance of pharmacokinetics in the development of biotechnology products

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Standardization and calibration of cytokine immunoassays: meeting report and recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Assaying tumor necrosis factor concentrations in human serum. A WHO International Collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

1 Statistical analysis of radioligand assay data

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

A strategy for validation of bioanalytical methods

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Method validation in the bioanalytical laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Direct microtitre plate enzyme immunoassay of folic acid without heat denaturation of serum

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Measurement and analysis of unbound drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Free drug concentration monitoring in clinical practice. Rationale and current status

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Growth hormone receptor and serum binding protein: purification, cloning and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Physiological role of the insulin-like growth factor binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Demonstration of a leptin binding factor in human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Immunoassays for detecting cytokines: What are they really measuring?

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Pharmacokinetic studies with recombinant cytokines. Scientific issues and practical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Influence of growth hormone binding protein on growth hormone estimation in different immunoassays

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Antibodies as carrier proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Calibration and validation of linearity in chromatographic biopharmaceutical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

On the estimation of total variability in assay validation

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Selecting and validating biologic markers for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

Surrogate Biochemical Markers: Precise Measurement for Strategic Drug and Biologics Development

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2899%2900244-7

7 January 2021

10.1016/S0731-7085(99)00244-7

Identifiers

DOI

1 reference

29 July 2017

1 reference